Announcements Trials

Browse Landscape

Phase

Status

Completed 4 Active not recruiting 2 Withdrawn 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 78 Prostatic Neoplasms 56 Breast Neoplasms 49 Lung Neoplasms 31 Neoplasms 20 Neoplasm Metastasis 18 Stomach Neoplasms 14 Head and Neck Neoplasms 13 Squamous Cell Carcinoma of Head and Neck 12 Recurrence 7 Pancreatic Neoplasms 7 Ovarian Neoplasms 7 Adenocarcinoma of Lung 7 Sarcoma 6 Esophageal Neoplasms 6 Carcinoma, Transitional Cell 5 Carcinoma, Squamous Cell 5 Urinary Bladder Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Triple Negative Breast Neoplasms 3 Advanced Non-Small Cell Lung Cancer 3 Adenocarcinoma, Bronchiolo-Alveolar 3 Solid Tumor 2 Small Cell Lung Carcinoma 2 Prostatic Neoplasms, Castration-Resistant 2 Inflammatory Breast Neoplasms 2 Hormone Refractory Prostate Cancer 2 HER2-positive Breast Cancer 2 Fallopian Tube Neoplasms 2

Interventions

Ifosfamide 6 Leucovorin 5 Doxorubicin 4 Dexrazoxane 4 Cisplatin 4 Methotrexate 3 Filgrastim 3 Carboplatin 3 mifamurtide 2 glucarpidase 2 Radiotherapy 2 Neoadjuvant Therapy 2 Mesna 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Granulocyte Colony-Stimulating Factor 2 Gemcitabine 2 Cryosurgery 2 Chemotherapy, Adjuvant 2 temsirolimus 1 sintilimab 1 sargramostim 1 saracatinib 1 samarium Sm-153 lexidronam 1 robatumumab 1 pembrolizumab 1 pegfilgrastim 1 pazopanib 1 omburtamab I-131 1 niraparib 1 lexatumumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Osteosarcoma × Docetaxel × Clear all

NCT02718482 2019-05-13

OsteoREC2015

Italian Sarcoma Group

Phase 2 Terminated

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡